drugset / Trial / NCT03029013
Apatinib and Chemotherapy Sequential Treatment With Cervical Cancer
NaSingle-groupOpen-labelTreatment
Summary
The study is the single arm and single center clinical trials,We conduct the phase II clinical trial to further explore the efficacy and safety of Apatinib and chemotherapy sequential treatment with advanced recurrence of metastatic cervical cancer
Timeline
- Start
- 2017-01
- Primary completion
- 2019-12
- Completion
- 2020-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rivoceranib | Small molecule | 250 mg | Oral |